Adiponectin: A new adipocytokine;L'adiponectine: Une nouvelle adipocytokine

Revue Medicale de Liege

Volumn 58, Issue 9, 2003, Pages 554-558

  Lebas, E ^b   Paquot, N ^a   Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE

Author keywords

Adipose tissue; Insulin resistance; Obesity; Thia; TNF ; Type 2 diabetes; Zolidinediones

Indexed keywords

ADIPONECTIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; THIAZOLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; CHROMOSOME 3Q; CIRCULATION; ENERGY; GENE LOCUS; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN SECRETION; REVIEW; TREATMENT PLANNING;

ADIPONECTIN; ADIPOSE TISSUE; CORONARY ARTERIOSCLEROSIS; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242287125     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Friedman JM.- Obesity in the new millenium. Nature, 2000, 404, 632-634.
2. Hotamisligil GS, Shargill NS, Spiegelman BM, et al.-Adipose expression of tumor necrosis factor-α. Direct role in obesity-linked insulin resistance. Science, 1993, 259, 87-91.
3. Steppan CM, Bailey ST, Bath S, et al.- The hormone resistin links obesity to diabetes. Nature, 2001, 409, 307-312.
4. Menzaghi C, Ercolino T, Di Paola R, et al.- A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes, 2002, 51, 2306-2312.
5. Yamauchi T, Kamon J, Waki H, et al.- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 2001, 7, 941-946.
6. Stumvoll M, Tschritter O, Fritsche A, et al.- Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity. Diabetes, 2002, 51, 37-41.
7. Yang WS, Lee WJ, Funahashi T, et al.- Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab, 2001, 86, 3815-3819.
8. Kondo H, Shimomura I, Matsukawa Y, et al.- Association of adiponectin mutation with type 2 diabetes. Diabetes, 2002, 51, 2325-2328.
9. Hara K, Boutin P, Mori Y, et al.- Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes, 2002, 51, 536-540.
10. Weiss R, Dufour S, Groszmann A, et al.- Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab, 2003, 88, 2014-2018.
11. Tschritter O, Fritsche A, Thamer C, et al.- Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes, 2003, 52, 239-243.
12. Maeda N, Shimomura I, Kishida K, et al.- Diet-induced insulin resistance in mice lacking adiponectin/ARCP30. Nature medicine, 2002, 8, 731-737.
13. Paquot N, Castillo MJ, Lefèbvre PJ, Scheen AJ.- No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin resistant patients. J Clin Endocrinol Metab, 2000, 85, 1316-1319.
14. Yu JG, Javorschi S, Hevener AL, et al.- The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 2002, 51, 2968-2974.
15. Maeda N, Takahashi M, Funahashi T, et al.- PPAR-γ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001, 50, 2094-2099.
16. Ouchi N, Kihara S, Arita Y et al.- Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavanger receptor expression in human monocyte-derived macrophages. Circulation, 2001, 103, 1057-1063.
17. Ouchi N, Kihara S, Arita Y, et al.- Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. Circulation, 2000, 102, 1296-1302
18. Arita Y, Kihara S, Ouchi N, et al.- Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999, 257, 79-83.
19. Nishizawa H, Shimomura I, Kishida K, et al.- Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes, 2002, 51, 2734-2741.
20. Yokota T, Oritani K, Takahashi I, et al.- Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 2000, 96, 1723-1732.
21. Tsunekawa T, Hayashi T, Suzuki Y, et al.- Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care, 2003, 26, 285-289.